Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality – Heart

Source: Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality — Anderson et al. 102 (21): 1750 — Heart

Hmm…

Leave a comment